Navigating Executive Orders and DOJ Memos That Threaten Criminal Prosecution
FDA Law Blog
MAY 26, 2025
Specifically, these are procedures and drugs used in providing what HHS had, until recently, referred to as gender-affirming care. Late last month the Attorney General issued a memo addressing both directives. 18-1156, 2018 U.S. The gray box at the top of the document at this link shows the change in position. MedImmune, Inc.
59 
Let's personalize your content